JP2023539367A5 - - Google Patents
Info
- Publication number
- JP2023539367A5 JP2023539367A5 JP2023514413A JP2023514413A JP2023539367A5 JP 2023539367 A5 JP2023539367 A5 JP 2023539367A5 JP 2023514413 A JP2023514413 A JP 2023514413A JP 2023514413 A JP2023514413 A JP 2023514413A JP 2023539367 A5 JP2023539367 A5 JP 2023539367A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- seq
- nucleic acid
- sequence
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073837P | 2020-09-02 | 2020-09-02 | |
| US63/073,837 | 2020-09-02 | ||
| PCT/US2021/048510 WO2022051294A1 (en) | 2020-09-02 | 2021-08-31 | Codon optimized rep1 genes and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539367A JP2023539367A (ja) | 2023-09-13 |
| JP2023539367A5 true JP2023539367A5 (cg-RX-API-DMAC7.html) | 2024-09-09 |
Family
ID=80356143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514413A Pending JP2023539367A (ja) | 2020-09-02 | 2021-08-31 | コドン最適化したｒｅｐ１遺伝子およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US11357870B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4208182A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023539367A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102888699B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116806158A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021337580B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023003840A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3191545A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300752A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022051294A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026030354A2 (en) * | 2024-07-29 | 2026-02-05 | Remedium Bio, Inc. | Optimized dna cassettes for gene therapy |
| CN119736306B (zh) * | 2025-02-26 | 2025-09-12 | 上海奥浦迈生物科技股份有限公司 | 一种Noggin蛋白的表达载体及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3008264A1 (en) * | 2015-12-14 | 2017-06-22 | The Trustees Of The University Of Pennsylvania | Gene therapy for ocular disorders |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| JP7766393B2 (ja) * | 2017-06-14 | 2025-11-10 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 眼疾患のための遺伝子療法 |
| WO2019195729A1 (en) * | 2018-04-05 | 2019-10-10 | Nightstarx Ltd. | Aav compositions, methods of making and methods of use |
-
2021
- 2021-08-31 AU AU2021337580A patent/AU2021337580B2/en active Active
- 2021-08-31 EP EP21864994.5A patent/EP4208182A4/en active Pending
- 2021-08-31 CN CN202180073005.5A patent/CN116806158A/zh active Pending
- 2021-08-31 BR BR112023003840A patent/BR112023003840A2/pt unknown
- 2021-08-31 CA CA3191545A patent/CA3191545A1/en active Pending
- 2021-08-31 IL IL300752A patent/IL300752A/en unknown
- 2021-08-31 JP JP2023514413A patent/JP2023539367A/ja active Pending
- 2021-08-31 KR KR1020237006989A patent/KR102888699B1/ko active Active
- 2021-08-31 WO PCT/US2021/048510 patent/WO2022051294A1/en not_active Ceased
- 2021-08-31 US US17/463,262 patent/US11357870B2/en active Active
-
2022
- 2022-05-09 US US17/740,045 patent/US11524081B2/en active Active
- 2022-11-04 US US18/052,735 patent/US20230158172A1/en active Pending
-
2024
- 2024-07-09 US US18/766,963 patent/US20240358859A1/en active Pending